Key Highlights

  • BillionToOne shares closed down 38.89% on August 6 at $91.65
  • The decline extends a sharp after-hours selloff triggered Wednesday by the company's Q2 2026 earnings report
  • Revenue rose 64% year over year and beat consensus by a wide margin
  • Adjusted EPS came in slightly below expectations, breaking a streak of consistent beats
  • Test volume grew 35% year over year

What Happened

BillionToOne (NASDAQ:BLLN) shares closed down 38.89% on August 6 at $91.65, extending a sharp after-hours selloff triggered Wednesday by its Q2 2026 earnings report released after market close. BillionToOne is a Menlo Park, California based precision diagnostics company, founded in 2016 by Oguzhan Atay and Dr. David Tsao, dedicated to making molecular diagnostics more powerful, efficient, and accessible through its patented Quantitative Counting Templates platform, which is capable of detecting and quantifying DNA molecules at single-molecule resolution, enabling highly sensitive disease detection.

Despite revenue rising 64% year over year and beating consensus by a wide margin, along with 35% test volume growth, adjusted EPS came in slightly below the level investors had grown accustomed to following a string of consistent beats, and investors reacted sharply to the deceleration in growth.

Insider Selling Adds to Pressure

Sentiment was further pressured by CEO Oguzhan Atay's roughly $6.2 million insider stock sale disclosed August 3, following an earlier sale by the CFO in June. BTIG reiterated a Buy rating on the stock while adjusting its price target following the report.

Conclusion

BillionToOne's close down 38.89% on August 6 reflects a sharp market reaction to decelerating growth and insider selling, even as the underlying business continues to post strong revenue and test volume growth.

This article is for informational purposes only and does not constitute financial or investment advice. Readers should conduct their own research or consult a financial professional before making investment decisions.